speb/financial-data huggingface dataset:
IVX.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3149000.00
IVX.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2329000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2329000.00
IVX.V balance_sheet (annual, 2025-12-31) — Total Tax Payable: 75000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 75000.00
IVX.V balance_sheet (annual, 2025-12-31) — Work In Process: 7000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Work In Process: 7000.00
IVX.V balance_sheet (annual, 2025-12-31) — Working Capital: 1761000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Working Capital: 1761000.00
IVX.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 95000.00
IVX.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 1727000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 600000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 871000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 403000.00
IVX.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 4871145.00
IVX.V income_statement (quarterly, 2026-03-31) — Basic EPS: 0.01
IVX.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 990000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -31000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1337000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 808000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 808000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Cash Financial: 808000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -80000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -31000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -71000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Change In Inventory: -153000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -12000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Change In Payable: 237000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 237000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Change In Receivables: -259000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -187000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -259000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: -182000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 1337000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2611000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
IVX.V income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1565000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 208000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 2784000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 203000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1021000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Depreciation: 55000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 55000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 55000.00
IVX.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 4871145.00
IVX.V income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.01
IVX.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 25000.00
IVX.V income_statement (quarterly, 2026-03-31) — EBIT: 67000.00
IVX.V income_statement (quarterly, 2026-03-31) — EBITDA: 122000.00
IVX.V cash_flow (quarterly, 2026-03-31) — End Cash Position: 808000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -80000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Finished Goods: 80000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -102000.00
IVX.V income_statement (quarterly, 2026-03-31) — Gross Profit: 162000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 0.00
IVX.V income_statement (quarterly, 2026-03-31) — Interest Expense: 31000.00
IVX.V income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 31000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -31000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Inventory: 1044000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Invested Capital: 4609000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -31000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1998000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1998000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -49000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Net Debt: 1190000.00
IVX.V income_statement (quarterly, 2026-03-31) — Net Income: 25000.00
IVX.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 25000.00
IVX.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 25000.00
IVX.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 25000.00
IVX.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 25000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 25000.00
IVX.V income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 25000.00
IVX.V income_statement (quarterly, 2026-03-31) — Net Interest Income: -31000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -49000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -49000.00
IVX.V income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -31000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Net PPE: 3125000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -31000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2611000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 279000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 279000.00
IVX.V income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 122000.00
IVX.V income_statement (quarterly, 2026-03-31) — Normalized Income: 25000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -71000.00
IVX.V income_statement (quarterly, 2026-03-31) — Operating Income: 67000.00
IVX.V income_statement (quarterly, 2026-03-31) — Operating Revenue: 1727000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 4871145.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 58000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 36000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Other Payable: 10000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Payables: 610000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 818000.00
IVX.V income_statement (quarterly, 2026-03-31) — Pretax Income: 36000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -31000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Raw Materials: 721000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Receivables: 874000.00
IVX.V income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1565000.00
IVX.V income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 55000.00
IVX.V cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -49000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 871000.00
IVX.V income_statement (quarterly, 2026-03-31) — Selling General And Administration: 95000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Share Issued: 4871145.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2611000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2611000.00
IVX.V income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
IVX.V income_statement (quarterly, 2026-03-31) — Tax Provision: 11000.00
IVX.V income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.31
IVX.V balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 3000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Total Assets: 5909000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 4609000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Total Debt: 2201000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2611000.00
IVX.V income_statement (quarterly, 2026-03-31) — Total Expenses: 1660000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3298000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3125000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2277000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Work In Process: 243000.00
IVX.V balance_sheet (quarterly, 2026-03-31) — Working Capital: 1763000.00
IVZ balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 0.00
IVZ income_statement (annual, 2021-12-31) — Gain On Sale Of Security: 61400000.00
IVZ cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
IVZ cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
IVZ balance_sheet (annual, 2021-12-31) — Other Receivables: 92800000.00
IVZ balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 510800000.00
IVZ balance_sheet (annual, 2021-12-31) — Prepaid Assets: 166000000.00
IVZ cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: -309400000.00
IVZ cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
IVZ income_statement (annual, 2021-12-31) — Write Off: 7100000.00
IVZ income_statement (annual, 2022-12-31) — +Operating Expense: 1098700000.00
IVZ income_statement (annual, 2022-12-31) — +Total Revenue: 6048900000.00
IVZ balance_sheet (annual, 2022-12-31) — Accounts Payable: 59600000.00
IVZ balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1005500000.00
IVZ balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1129800000.00
IVZ balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 7554900000.00
IVZ income_statement (annual, 2022-12-31) — Amortization: 63800000.00
IVZ income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 63800000.00
IVZ cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
IVZ balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 7171400000.00
IVZ income_statement (annual, 2022-12-31) — Basic Average Shares: 457500000.00
IVZ income_statement (annual, 2022-12-31) — Basic EPS: 1.50
IVZ cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2147100000.00
IVZ cash_flow (annual, 2022-12-31) — Capital Expenditure: -192900000.00
IVZ balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 480200000.00
IVZ balance_sheet (annual, 2022-12-31) — Capital Stock: 4123700000.00
IVZ balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1434100000.00
IVZ balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1434100000.00
IVZ cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -571600000.00
IVZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -966900000.00
IVZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -375600000.00
IVZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 703200000.00
IVZ cash_flow (annual, 2022-12-31) — Change In Payable: -1284300000.00
IVZ cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -1284300000.00
IVZ cash_flow (annual, 2022-12-31) — Change In Receivables: 912800000.00
IVZ cash_flow (annual, 2022-12-31) — Change In Working Capital: -371500000.00
IVZ cash_flow (annual, 2022-12-31) — Changes In Cash: -639300000.00
IVZ balance_sheet (annual, 2022-12-31) — Common Stock: 113200000.00
IVZ cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -334800000.00
IVZ balance_sheet (annual, 2022-12-31) — Common Stock Equity: 11203100000.00
IVZ cash_flow (annual, 2022-12-31) — Common Stock Payments: -244700000.00
IVZ balance_sheet (annual, 2022-12-31) — Construction In Progress: 173100000.00
IVZ income_statement (annual, 2022-12-31) — Cost Of Revenue: 3611300000.00
IVZ balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 606500000.00
IVZ balance_sheet (annual, 2022-12-31) — Current Assets: 8754700000.00
IVZ balance_sheet (annual, 2022-12-31) — Current Liabilities: 1503300000.00
IVZ cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 195300000.00
IVZ income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 63800000.00
IVZ cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 195300000.00
IVZ income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 63800000.00
IVZ income_statement (annual, 2022-12-31) — Diluted Average Shares: 459500000.00
IVZ income_statement (annual, 2022-12-31) — Diluted EPS: 1.49
IVZ income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 683900000.00
IVZ cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 74200000.00
IVZ cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 32600000.00
IVZ income_statement (annual, 2022-12-31) — EBIT: 1332900000.00
IVZ income_statement (annual, 2022-12-31) — EBITDA: 1528200000.00
IVZ income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 106100000.00
IVZ cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -106100000.00
IVZ cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -73700000.00
IVZ balance_sheet (annual, 2022-12-31) — Employee Benefits: 860800000.00
IVZ cash_flow (annual, 2022-12-31) — End Cash Position: 1434100000.00
IVZ cash_flow (annual, 2022-12-31) — Financing Cash Flow: -966900000.00
IVZ cash_flow (annual, 2022-12-31) — Free Cash Flow: 510300000.00
IVZ cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 126900000.00
IVZ balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -942400000.00
IVZ income_statement (annual, 2022-12-31) — General And Administrative Expense: 493600000.00
IVZ balance_sheet (annual, 2022-12-31) — Goodwill: 8557700000.00
IVZ balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 15698900000.00
IVZ balance_sheet (annual, 2022-12-31) — Gross PPE: 1690900000.00
IVZ income_statement (annual, 2022-12-31) — Gross Profit: 2437600000.00
IVZ balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 697500000.00
IVZ cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 301400000.00
IVZ balance_sheet (annual, 2022-12-31) — Income Tax Payable: 89100000.00
IVZ income_statement (annual, 2022-12-31) — Interest Expense: 85200000.00
IVZ income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 85200000.00
IVZ income_statement (annual, 2022-12-31) — Interest Income: 24400000.00
IVZ income_statement (annual, 2022-12-31) — Interest Income Non Operating: 24400000.00
IVZ cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 67400000.00
IVZ balance_sheet (annual, 2022-12-31) — Invested Capital: 19281100000.00
IVZ cash_flow (annual, 2022-12-31) — Investing Cash Flow: -375600000.00
IVZ balance_sheet (annual, 2022-12-31) — Investment Properties: 552000000.00
IVZ balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 1553800000.00
IVZ balance_sheet (annual, 2022-12-31) — Investments And Advances: 2660900000.00
IVZ balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 1082400000.00
IVZ balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 621200000.00
IVZ cash_flow (annual, 2022-12-31) — Issuance Of Debt: 30100000.00
IVZ balance_sheet (annual, 2022-12-31) — Land And Improvements: 87800000.00
IVZ balance_sheet (annual, 2022-12-31) — Leases: 226200000.00
IVZ balance_sheet (annual, 2022-12-31) — Loans Receivable: 6315100000.00
IVZ balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 480200000.00
IVZ balance_sheet (annual, 2022-12-31) — Long Term Debt: 8078000000.00
IVZ balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 8558200000.00
IVZ cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 30100000.00
IVZ cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -605100000.00
IVZ balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 1082400000.00
IVZ balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1203800000.00
IVZ balance_sheet (annual, 2022-12-31) — Minority Interest: 1628600000.00
IVZ income_statement (annual, 2022-12-31) — Minority Interests: -4800000.00
IVZ cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -244700000.00
IVZ balance_sheet (annual, 2022-12-31) — Net Debt: 6643900000.00
IVZ income_statement (annual, 2022-12-31) — Net Income: 920700000.00
IVZ income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 683900000.00
IVZ income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 925500000.00
IVZ income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 920700000.00
IVZ income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 920700000.00
IVZ cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 925500000.00
IVZ income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 925500000.00
IVZ income_statement (annual, 2022-12-31) — Net Interest Income: -60800000.00
IVZ cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -215300000.00
IVZ cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -575000000.00
IVZ cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -575000000.00
IVZ income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -60800000.00
IVZ cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 424400000.00
IVZ balance_sheet (annual, 2022-12-31) — Net PPE: 561100000.00
IVZ cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -192900000.00
IVZ balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -485300000.00
IVZ balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 1662700000.00
IVZ balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 1662700000.00
IVZ balance_sheet (annual, 2022-12-31) — Non Current Note Receivables: 6315100000.00
IVZ income_statement (annual, 2022-12-31) — Normalized EBITDA: 1549400000.00
IVZ income_statement (annual, 2022-12-31) — Normalized Income: 936430400.00
IVZ cash_flow (annual, 2022-12-31) — Operating Cash Flow: 703200000.00
IVZ cash_flow (annual, 2022-12-31) — Operating Gains Losses: 20800000.00
IVZ income_statement (annual, 2022-12-31) — Operating Income: 1338900000.00
IVZ income_statement (annual, 2022-12-31) — Operating Revenue: 5832100000.00
IVZ balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 454800000.00
IVZ balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -942400000.00
IVZ income_statement (annual, 2022-12-31) — Other Gand A: 493600000.00
IVZ income_statement (annual, 2022-12-31) — Other Income Expense: -30400000.00
IVZ balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 7141200000.00
IVZ balance_sheet (annual, 2022-12-31) — Other Investments: 24700000.00
IVZ cash_flow (annual, 2022-12-31) — Other Non Cash Items: -247300000.00
IVZ balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1529200000.00
IVZ balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 329600000.00
IVZ income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -115300000.00
IVZ income_statement (annual, 2022-12-31) — Other Operating Expenses: 446700000.00
IVZ balance_sheet (annual, 2022-12-31) — Other Payable: 748100000.00
IVZ balance_sheet (annual, 2022-12-31) — Payables: 896800000.00
IVZ balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1503300000.00
IVZ balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 998700000.00
IVZ balance_sheet (annual, 2022-12-31) — Preferred Stock: 4010500000.00
IVZ cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -236800000.00
IVZ income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 236800000.00
IVZ balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 4010500000.00
IVZ income_statement (annual, 2022-12-31) — Pretax Income: 1247700000.00
IVZ cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
IVZ balance_sheet (annual, 2022-12-31) — Properties: 0.00
IVZ cash_flow (annual, 2022-12-31) — Purchase Of Investment: -2951600000.00
IVZ cash_flow (annual, 2022-12-31) — Purchase Of PPE: -192900000.00
IVZ balance_sheet (annual, 2022-12-31) — Receivables: 7320600000.00
IVZ income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 3479800000.00
IVZ income_statement (annual, 2022-12-31) — Reconciled Depreciation: 195300000.00
IVZ cash_flow (annual, 2022-12-31) — Repayment Of Debt: -605100000.00
IVZ cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -244700000.00
IVZ income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 21200000.00
IVZ balance_sheet (annual, 2022-12-31) — Retained Earnings: 7518300000.00
IVZ cash_flow (annual, 2022-12-31) — Sale Of Investment: 2736300000.00
IVZ income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 94600000.00
IVZ income_statement (annual, 2022-12-31) — Selling General And Administration: 588200000.00
IVZ balance_sheet (annual, 2022-12-31) — Share Issued: 566100000.00
IVZ income_statement (annual, 2022-12-31) — Special Income Charges: -21200000.00
IVZ cash_flow (annual, 2022-12-31) — Stock Based Compensation: 106200000.00
IVZ balance_sheet (annual, 2022-12-31) — Stockholders Equity: 15213600000.00
IVZ balance_sheet (annual, 2022-12-31) — Tangible Book Value: -4495800000.00
IVZ income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -5469600.00
IVZ income_statement (annual, 2022-12-31) — Tax Provision: 322200000.00
IVZ income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
IVZ balance_sheet (annual, 2022-12-31) — Total Assets: 29756800000.00
IVZ balance_sheet (annual, 2022-12-31) — Total Capitalization: 23291600000.00
IVZ balance_sheet (annual, 2022-12-31) — Total Debt: 8558200000.00
IVZ balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 16842200000.00
IVZ income_statement (annual, 2022-12-31) — Total Expenses: 4710000000.00
IVZ balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 12914600000.00
IVZ balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 21002100000.00
IVZ balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 11411300000.00
IVZ income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 1317700000.00
IVZ balance_sheet (annual, 2022-12-31) — Total Tax Payable: 89100000.00
IVZ income_statement (annual, 2022-12-31) — Total Unusual Items: -21200000.00
IVZ income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -21200000.00
IVZ balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 111300000.00
IVZ balance_sheet (annual, 2022-12-31) — Treasury Stock: 3040900000.00
IVZ balance_sheet (annual, 2022-12-31) — Working Capital: 7251400000.00
IVZ income_statement (annual, 2023-12-31) — +Operating Expense: 2398600000.00
IVZ income_statement (annual, 2023-12-31) — +Total Revenue: 5716400000.00
IVZ balance_sheet (annual, 2023-12-31) — Accounts Payable: 31500000.00
IVZ balance_sheet (annual, 2023-12-31) — Accounts Receivable: 951600000.00
IVZ balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -944700000.00
IVZ balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 7451600000.00
IVZ income_statement (annual, 2023-12-31) — Amortization: 1298800000.00
IVZ income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 1298800000.00
IVZ cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 1248900000.00
IVZ balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 642200000.00
IVZ income_statement (annual, 2023-12-31) — Basic Average Shares: 454800000.00
IVZ income_statement (annual, 2023-12-31) — Basic EPS: -0.73
IVZ cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1434100000.00
IVZ cash_flow (annual, 2023-12-31) — Capital Expenditure: -164300000.00
IVZ balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 433700000.00
IVZ balance_sheet (annual, 2023-12-31) — Capital Stock: 4123700000.00
IVZ balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 1931600000.00
IVZ balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 1931600000.00
IVZ cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -594700000.00
IVZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -585400000.00
IVZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -244300000.00
IVZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 1300800000.00
IVZ cash_flow (annual, 2023-12-31) — Change In Payable: -621700000.00
IVZ cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -621700000.00
IVZ cash_flow (annual, 2023-12-31) — Change In Receivables: 448700000.00
IVZ cash_flow (annual, 2023-12-31) — Change In Working Capital: -173000000.00
IVZ cash_flow (annual, 2023-12-31) — Changes In Cash: 471100000.00
IVZ balance_sheet (annual, 2023-12-31) — Common Stock: 113200000.00
IVZ cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -357900000.00
IVZ balance_sheet (annual, 2023-12-31) — Common Stock Equity: 10587100000.00
IVZ cash_flow (annual, 2023-12-31) — Common Stock Payments: -187500000.00
IVZ balance_sheet (annual, 2023-12-31) — Construction In Progress: 111600000.00
IVZ income_statement (annual, 2023-12-31) — Cost Of Revenue: 3711000000.00
IVZ balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 567500000.00
IVZ balance_sheet (annual, 2023-12-31) — Current Assets: 9720400000.00
IVZ balance_sheet (annual, 2023-12-31) — Current Liabilities: 1254600000.00
IVZ cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 182800000.00
IVZ income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 1298800000.00
IVZ cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 182800000.00
IVZ income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 1298800000.00
IVZ income_statement (annual, 2023-12-31) — Diluted Average Shares: 456200000.00
IVZ income_statement (annual, 2023-12-31) — Diluted EPS: -0.73
IVZ income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -333700000.00
IVZ cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 69400000.00
IVZ cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 23300000.00
IVZ income_statement (annual, 2023-12-31) — EBIT: -167400000.00
IVZ income_statement (annual, 2023-12-31) — EBITDA: 1131400000.00
IVZ income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 71300000.00
IVZ cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -71300000.00
IVZ cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 26400000.00
IVZ balance_sheet (annual, 2023-12-31) — Employee Benefits: 900400000.00
IVZ cash_flow (annual, 2023-12-31) — End Cash Position: 1931600000.00
IVZ cash_flow (annual, 2023-12-31) — Financing Cash Flow: -585400000.00
IVZ cash_flow (annual, 2023-12-31) — Free Cash Flow: 1136500000.00
IVZ cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 176300000.00
IVZ balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -801800000.00
IVZ income_statement (annual, 2023-12-31) — General And Administrative Expense: 567600000.00
IVZ balance_sheet (annual, 2023-12-31) — Goodwill: 8691500000.00
IVZ balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 14539600000.00
IVZ balance_sheet (annual, 2023-12-31) — Gross PPE: 1544200000.00
IVZ income_statement (annual, 2023-12-31) — Gross Profit: 2005400000.00
IVZ balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 669800000.00
IVZ cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 195100000.00
IVZ balance_sheet (annual, 2023-12-31) — Income Tax Payable: 110500000.00
IVZ income_statement (annual, 2023-12-31) — Interest Expense: 70500000.00
IVZ income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 70500000.00
IVZ income_statement (annual, 2023-12-31) — Interest Income: 47800000.00
IVZ income_statement (annual, 2023-12-31) — Interest Income Non Operating: 47800000.00
IVZ cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 68200000.00
IVZ balance_sheet (annual, 2023-12-31) — Invested Capital: 19198400000.00
IVZ cash_flow (annual, 2023-12-31) — Investing Cash Flow: -244300000.00
IVZ balance_sheet (annual, 2023-12-31) — Investment Properties: 463600000.00
IVZ balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 1312000000.00
IVZ balance_sheet (annual, 2023-12-31) — Investments And Advances: 2384200000.00
IVZ balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 1057300000.00
IVZ balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 631800000.00
IVZ cash_flow (annual, 2023-12-31) — Issuance Of Debt: 703000000.00
IVZ balance_sheet (annual, 2023-12-31) — Land And Improvements: 87300000.00
IVZ balance_sheet (annual, 2023-12-31) — Leases: 277700000.00
IVZ balance_sheet (annual, 2023-12-31) — Loans Receivable: 6837200000.00
IVZ balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 433700000.00
IVZ balance_sheet (annual, 2023-12-31) — Long Term Debt: 8611300000.00
IVZ balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 9045000000.00
IVZ cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 703000000.00
IVZ cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -451800000.00
IVZ balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 1057300000.00
IVZ balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1067600000.00
IVZ balance_sheet (annual, 2023-12-31) — Minority Interest: 1318400000.00
IVZ income_statement (annual, 2023-12-31) — Minority Interests: 71300000.00
IVZ cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
IVZ cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -187500000.00
IVZ balance_sheet (annual, 2023-12-31) — Net Debt: 6679700000.00
IVZ income_statement (annual, 2023-12-31) — Net Income: -96900000.00
IVZ income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -333700000.00
IVZ income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -168200000.00
IVZ income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -96900000.00
IVZ income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -96900000.00
IVZ cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -168200000.00
IVZ income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -168200000.00
IVZ income_statement (annual, 2023-12-31) — Net Interest Income: -22700000.00
IVZ cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -149500000.00
IVZ cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 251200000.00
IVZ cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 251200000.00
IVZ income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -22700000.00
IVZ cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -54400000.00
IVZ cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 46200000.00
IVZ balance_sheet (annual, 2023-12-31) — Net PPE: 599500000.00
IVZ cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -164300000.00
IVZ cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
IVZ balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 58000000.00
IVZ balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 1325700000.00
IVZ balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 1325700000.00
IVZ balance_sheet (annual, 2023-12-31) — Non Current Note Receivables: 6837200000.00
IVZ income_statement (annual, 2023-12-31) — Normalized EBITDA: 1173000000.00
IVZ income_statement (annual, 2023-12-31) — Normalized Income: -67488800.00
IVZ cash_flow (annual, 2023-12-31) — Operating Cash Flow: 1300800000.00
IVZ cash_flow (annual, 2023-12-31) — Operating Gains Losses: 105000000.00
IVZ income_statement (annual, 2023-12-31) — Operating Income: -393200000.00
IVZ income_statement (annual, 2023-12-31) — Operating Revenue: 5527300000.00
IVZ balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 449500000.00
IVZ balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -801800000.00
IVZ income_statement (annual, 2023-12-31) — Other Gand A: 567600000.00
IVZ income_statement (annual, 2023-12-31) — Other Income Expense: 178000000.00
IVZ balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 5848100000.00
IVZ balance_sheet (annual, 2023-12-31) — Other Investments: 14900000.00
IVZ cash_flow (annual, 2023-12-31) — Other Non Cash Items: -78700000.00
IVZ balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1226500000.00
IVZ balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 492100000.00
IVZ income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 148300000.00
IVZ income_statement (annual, 2023-12-31) — Other Operating Expenses: 450100000.00
IVZ balance_sheet (annual, 2023-12-31) — Other Payable: 545100000.00
IVZ income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
IVZ balance_sheet (annual, 2023-12-31) — Payables: 687100000.00
IVZ balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1254600000.00
IVZ balance_sheet (annual, 2023-12-31) — Preferred Stock: 4010500000.00
IVZ cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: -236800000.00
IVZ income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 236800000.00
IVZ balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 4010500000.00
IVZ cash_flow (annual, 2023-12-31) — Preferred Stock Payments: 0.00
IVZ income_statement (annual, 2023-12-31) — Pretax Income: -237900000.00
IVZ cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
IVZ balance_sheet (annual, 2023-12-31) — Properties: 0.00
IVZ cash_flow (annual, 2023-12-31) — Purchase Of Investment: -3287900000.00
IVZ cash_flow (annual, 2023-12-31) — Purchase Of PPE: -164300000.00
IVZ balance_sheet (annual, 2023-12-31) — Receivables: 7788800000.00
IVZ income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 4827000000.00
IVZ income_statement (annual, 2023-12-31) — Reconciled Depreciation: 182800000.00
IVZ cash_flow (annual, 2023-12-31) — Repayment Of Debt: -451800000.00
IVZ cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -187500000.00
IVZ income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 41600000.00
IVZ balance_sheet (annual, 2023-12-31) — Retained Earnings: 6826700000.00
IVZ cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
IVZ cash_flow (annual, 2023-12-31) — Sale Of Investment: 3138400000.00
IVZ income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 82100000.00
IVZ income_statement (annual, 2023-12-31) — Selling General And Administration: 649700000.00
IVZ balance_sheet (annual, 2023-12-31) — Share Issued: 566100000.00
IVZ income_statement (annual, 2023-12-31) — Special Income Charges: -41600000.00
IVZ cash_flow (annual, 2023-12-31) — Stock Based Compensation: 114600000.00
IVZ balance_sheet (annual, 2023-12-31) — Stockholders Equity: 14597600000.00
IVZ balance_sheet (annual, 2023-12-31) — Tangible Book Value: -3952500000.00
IVZ income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -12188800.00
IVZ income_statement (annual, 2023-12-31) — Tax Provision: -69700000.00
IVZ income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.29
IVZ balance_sheet (annual, 2023-12-31) — Total Assets: 28933800000.00
IVZ balance_sheet (annual, 2023-12-31) — Total Capitalization: 23208900000.00
IVZ balance_sheet (annual, 2023-12-31) — Total Debt: 9045000000.00
IVZ balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 15916000000.00
IVZ income_statement (annual, 2023-12-31) — Total Expenses: 6109600000.00
IVZ balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 13017800000.00
IVZ balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 19213400000.00
IVZ balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 11763200000.00
IVZ income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -434800000.00
IVZ balance_sheet (annual, 2023-12-31) — Total Tax Payable: 110500000.00
IVZ income_statement (annual, 2023-12-31) — Total Unusual Items: -41600000.00
IVZ income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -41600000.00
IVZ balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 116600000.00
IVZ balance_sheet (annual, 2023-12-31) — Treasury Stock: 3002600000.00
IVZ balance_sheet (annual, 2023-12-31) — Working Capital: 8465800000.00
IVZ income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
IVZ income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
IVZ income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
IVZ income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
IVZ income_statement (annual, 2024-12-31) — +Operating Expense: 1195100000.00
IVZ income_statement (annual, 2024-12-31) — +Total Revenue: 6067000000.00
IVZ balance_sheet (annual, 2024-12-31) — Accounts Payable: 30600000.00
IVZ balance_sheet (annual, 2024-12-31) — Accounts Receivable: 1113100000.00
IVZ balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -954700000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -954700000.00
IVZ balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 7334600000.00
IVZ income_statement (annual, 2024-12-31) — Amortization: 44800000.00
IVZ income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 44800000.00
IVZ cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
IVZ balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 612200000.00
IVZ income_statement (annual, 2024-12-31) — Basic Average Shares: 457000000.00
IVZ income_statement (annual, 2024-12-31) — Basic EPS: 1.18
IVZ cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1931600000.00
IVZ cash_flow (annual, 2024-12-31) — Capital Expenditure: -69100000.00
IVZ balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 454900000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 454900000.00
IVZ balance_sheet (annual, 2024-12-31) — Capital Stock: 4123700000.00
IVZ balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1496000000.00
IVZ balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1496000000.00
IVZ cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -608300000.00
IVZ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -1661600000.00
IVZ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 68400000.00
IVZ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 1190000000.00
IVZ cash_flow (annual, 2024-12-31) — Change In Payable: -173500000.00
IVZ cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -173500000.00
IVZ cash_flow (annual, 2024-12-31) — Change In Receivables: 319700000.00
IVZ cash_flow (annual, 2024-12-31) — Change In Working Capital: 146200000.00
IVZ cash_flow (annual, 2024-12-31) — Changes In Cash: -403200000.00
IVZ balance_sheet (annual, 2024-12-31) — Common Stock: 113200000.00
IVZ cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -371500000.00
IVZ balance_sheet (annual, 2024-12-31) — Common Stock Equity: 10549400000.00
IVZ cash_flow (annual, 2024-12-31) — Common Stock Payments: -79300000.00
IVZ balance_sheet (annual, 2024-12-31) — Construction In Progress: 62400000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 62400000.00
IVZ income_statement (annual, 2024-12-31) — Cost Of Revenue: 4039800000.00
IVZ balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 584400000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 584400000.00
IVZ balance_sheet (annual, 2024-12-31) — Current Assets: 8402100000.00
IVZ balance_sheet (annual, 2024-12-31) — Current Liabilities: 830400000.00
IVZ cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 179600000.00
IVZ income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 44800000.00
IVZ cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 179600000.00
IVZ income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 44800000.00
IVZ income_statement (annual, 2024-12-31) — Diluted Average Shares: 457700000.00
IVZ income_statement (annual, 2024-12-31) — Diluted EPS: 1.18
IVZ income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 538000000.00
IVZ cash_flow (annual, 2024-12-31) — Dividend Received Cfo: 82100000.00
IVZ cash_flow (annual, 2024-12-31) — Dividends Received Cfi: 126800000.00
IVZ income_statement (annual, 2024-12-31) — EBIT: 1063300000.00
IVZ income_statement (annual, 2024-12-31) — EBITDA: 1242900000.00
IVZ income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 43000000.00
IVZ cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -43000000.00
IVZ cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -32400000.00
IVZ balance_sheet (annual, 2024-12-31) — Employee Benefits: 1029200000.00
IVZ cash_flow (annual, 2024-12-31) — End Cash Position: 1496000000.00
IVZ cash_flow (annual, 2024-12-31) — Financing Cash Flow: -1661600000.00
IVZ cash_flow (annual, 2024-12-31) — Free Cash Flow: 1120900000.00
IVZ cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 57900000.00
IVZ balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1036100000.00
IVZ income_statement (annual, 2024-12-31) — General And Administrative Expense: 594700000.00
IVZ balance_sheet (annual, 2024-12-31) — Goodwill: 8318100000.00
IVZ balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 14067400000.00
IVZ balance_sheet (annual, 2024-12-31) — Gross PPE: 1433700000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Gross PPE: 1433700000.00
IVZ income_statement (annual, 2024-12-31) — Gross Profit: 2027200000.00
IVZ balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 605500000.00
IVZ cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 236300000.00
IVZ balance_sheet (annual, 2024-12-31) — Income Tax Payable: 146000000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 146000000.00
IVZ income_statement (annual, 2024-12-31) — Interest Expense: 58000000.00
IVZ income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 58000000.00
IVZ income_statement (annual, 2024-12-31) — Interest Income: 58900000.00
IVZ income_statement (annual, 2024-12-31) — Interest Income Non Operating: 58900000.00
IVZ cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 53600000.00
IVZ balance_sheet (annual, 2024-12-31) — Invested Capital: 17640900000.00
IVZ cash_flow (annual, 2024-12-31) — Investing Cash Flow: 68400000.00
IVZ balance_sheet (annual, 2024-12-31) — Investment Properties: 438600000.00
IVZ balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 1217700000.00
IVZ balance_sheet (annual, 2024-12-31) — Investments And Advances: 2501100000.00
IVZ balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 1269100000.00
IVZ cash_flow (annual, 2024-12-31) — Issuance Of Debt: 3758300000.00
IVZ balance_sheet (annual, 2024-12-31) — Land And Improvements: 85200000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 85200000.00
IVZ balance_sheet (annual, 2024-12-31) — Leases: 267300000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Leases: 267300000.00
IVZ balance_sheet (annual, 2024-12-31) — Loans Receivable: 5793000000.00
IVZ balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 454900000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 454900000.00
IVZ balance_sheet (annual, 2024-12-31) — Long Term Debt: 7091500000.00
IVZ balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 7546400000.00
IVZ cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 3758300000.00
IVZ cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -4681200000.00
IVZ balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 1269100000.00
IVZ balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1018800000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1018800000.00
IVZ balance_sheet (annual, 2024-12-31) — Minority Interest: 1108900000.00
IVZ income_statement (annual, 2024-12-31) — Minority Interests: 22400000.00
IVZ cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
IVZ cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -79300000.00
IVZ balance_sheet (annual, 2024-12-31) — Net Debt: 5595500000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Net Debt: 5595500000.00
IVZ income_statement (annual, 2024-12-31) — Net Income: 774800000.00
IVZ income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 538000000.00
IVZ income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 752400000.00
IVZ income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 774800000.00
IVZ income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 774800000.00
IVZ cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 752400000.00
IVZ income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 752400000.00
IVZ income_statement (annual, 2024-12-31) — Net Interest Income: 900000.00
IVZ cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 10700000.00
IVZ cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -922900000.00
IVZ cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -922900000.00
IVZ income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 900000.00
IVZ cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -51100000.00
IVZ balance_sheet (annual, 2024-12-31) — Net PPE: 479000000.00
IVZ cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -69100000.00
IVZ cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
IVZ balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 492500000.00
IVZ balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1281900000.00
IVZ balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1281900000.00
IVZ balance_sheet (annual, 2024-12-31) — Non Current Note Receivables: 5793000000.00
IVZ balance_sheet (quarterly, 2024-12-31) — Non Current Note Receivables: 5793000000.00
IVZ income_statement (annual, 2024-12-31) — Normalized EBITDA: 1242900000.00
IVZ income_statement (annual, 2024-12-31) — Normalized Income: 774800000.00
IVZ cash_flow (annual, 2024-12-31) — Operating Cash Flow: 1190000000.00